Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Mar;29(3-4):254-8.
doi: 10.1007/BF01966455.

Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytes in vitro

Affiliations

Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytes in vitro

J Kunert-Radek et al. Agents Actions. 1990 Mar.

Abstract

The effects of nimodipine (voltage-dependent calcium channel blocker), CGP 28392 and BAY K 8644 (novel dihydropyridine derivatives that are considered as calcium entry stimulators) on the spontaneous proliferation of mouse spleen lymphocytes were studied in vitro. [3H]-thymidine incorporation into DNA of lymphocytes was used as an sensitive index of the cell proliferation. It has been found that nimodipine (10(-4) M-10(-6) M) significantly inhibited the [3H]-thymidine uptake in a dose dependent fashion with ED50 value of 2.4 x 10(-5) M. Unexpectedly, CGP 28392 (10(-4) M-10(-7) M) acts as a calcium entry blocker and produces a strong inhibitory effect on lymphocyte proliferation (ED50-2 x 10(-5) M). BAY K 8644 at a high concentration (10(-4) M) also has an inhibitory effect but at a lower concentration (10(-6) M-10(-10) M) significantly increased [3H]-thymidine uptake and abolished the inhibitory effect of nimodipine. This effect of nimodipine was also reversed by 5 x 10(-3) M calcium chloride. These findings indicate that calcium channel modulators can regulate the proliferation of mouse spleen lymphocytes in vitro.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6069-72 - PubMed
    1. Can J Physiol Pharmacol. 1987 Dec;65(12):2409-14 - PubMed
    1. J Pharmacol Exp Ther. 1987 Nov;243(2):646-56 - PubMed
    1. Biochem Biophys Res Commun. 1985 Feb 28;127(1):71-9 - PubMed
    1. Can J Physiol Pharmacol. 1984 Nov;62(11):1401-10 - PubMed

MeSH terms